| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TFF Pharmaceuticals, Inc. | President and CEO, Director | Common Stock | 36,000 | $14,098 | $0.3916 | 16 May 2022 | Direct |
| TFF Pharmaceuticals, Inc. | President and CEO, Director | Common Stock | 7,000 | $2,741 | $0.3916 | 16 May 2022 | Shares held by spouse |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000121390022027791-mattes-glenn-r-2022-05-16 | TFF Pharmaceuticals, Inc. | 16 May 2022 | 1 | +$76,480 | 4 | President and CEO, Director | 17 May 2022, 21:51 |
| /report/000121390021048369-mattes-glenn-r-2021-09-16 | TFF Pharmaceuticals, Inc. | 16 Sep 2021 | 1 | +$71,000 | 4 | President and CEO, Director | 16 Sep 2021, 13:35 |